oxotremorine has been researched along with Gelineau Syndrome in 1 studies
Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both rapid eye movement sleep and cataplexy in the narcoleptic canine have been shown to increase after both systemic and local administration of cholinergic agonists in the pontine reticular formation." | 1.29 | Cholinergic regulation of cataplexy in canine narcolepsy in the pontine reticular formation is mediated by M2 muscarinic receptors. ( Dement, WC; Mignot, E; Nishino, S; Reid, MS; Siegel, JM; Tafti, M, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reid, MS | 1 |
| Tafti, M | 1 |
| Nishino, S | 1 |
| Siegel, JM | 1 |
| Dement, WC | 1 |
| Mignot, E | 1 |
1 other study available for oxotremorine and Gelineau Syndrome
| Article | Year |
|---|---|
Cholinergic regulation of cataplexy in canine narcolepsy in the pontine reticular formation is mediated by M2 muscarinic receptors.
Topics: Animals; Cataplexy; Dogs; Electroencephalography; Female; Male; Microdialysis; Muscimol; Narcolepsy; | 1994 |